Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Comparative risk of thrombosis in adults with primary immune thrombocytopenia treated with eltrombopag versus romiplostim: A target trial emulation in the french adult immune thrombocytopenia (FAITH) cohort

Jérémy Zordan, Yoann Zadro, Agnès Sommet, Maryse Lapeyre-Mestre, Guillaume Moulis, Margaux Lafaurie

Blood (2025) 146 (Supplement 1): 1251.

https://doi.org/10.1182/blood-2025-1251

Published: 2025

Journal Articles

Association between sars-cov-2 infection, COVID-19 vaccines and immune thrombocytopenia in adults. a nationwide population-based study in France.

Margaux Lafaurie, Jérémy Zordan, Yoann Zadro, Axel Renoux, Maryse Lapeyre-Mestre, Agnès Sommet, Guillaume Moulis

Blood (2025) 146 (Supplement 1): 1325.

https://doi.org/10.1182/blood-2025-1325

Published: 2025

Journal Articles

Real-world effectiveness and safety of fostamatinib in difficult-to-treat patients: Results of a three-year registry in France.

Blood (2025) 146 (Supplement 1): 4805.

https://doi.org/10.1182/blood-2025-4805

Published: 2025

Journal Articles

Risk of Acute Myeloid Leukemia in Adults with Primary Immune Thrombocytopenia Treated with Thrombopoietin Receptor Agonists: A French Nationwide Population-Based Study

Yoann Zadro, Margaux Lafaurie, Maryse Lapeyre-Mestre, Guillaume Moulis

Blood (2024) 144 (Supplement 1): 549.

https://doi.org/10.1182/blood-2024-200178

Published: 2024

Journal Articles

Hospitalization for Infection in Patients with Primary Autoimmune Hemolytic Anemia Treated with Rituximab. a Prospective, Nationwide Cohort Study in France

Yoann Zadro, Margaux Lafaurie, Maryse Lapeyre-Mestre, Marc Michel, Guillaume Moulis

Blood (2023) 142 (Supplement 1): 1082.

https://doi.org/10.1182/blood-2023-173444

Published: 2023

Journal Articles

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

Natasha Ollier, Marie-Léa Piel-Julian, Matthieu Mahévas, Jean-François Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikaël Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau, Guillaume Moulis

Blood (2023) 142 (12): 1099–1101.

https://doi.org/10.1182/blood.2023020311

Published: 2023

Includes: Supplemental data

Journal Articles

Drug-Induced Autoimmune Hemolytic Anemia: Detection of New Signals in the World Pharmacovigilance Database and Risk Assessment in a Nationwide Cohort Study in France

Julien Maquet, Margaux Lafaurie, Marc Michel, Maryse Lapeyre-Mestre, Guillaume Moulis

Blood (2022) 140 (Supplement 1): 8176–8177.

https://doi.org/10.1182/blood-2022-157730

Published: 2022

Journal Articles

Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

Natacha Ollier, Marie-Léa Piel-Julian, Matthieu Mahevas, Jean-Francois Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau, Guillaume Moulis

Blood (2022) 140 (Supplement 1): 52–54.

https://doi.org/10.1182/blood-2022-157715

Published: 2022

Journal Articles

Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

Guillaume Moulis, Manuela Rueter, Matthieu Mahevas, Jean-Francois Viallard, Thibault Comont, Stéphane Chèze, Sylvain Audia, Mikael Ebbo, Louis Terriou, Jean-Christophe Lega, Pierre-Yves Jeandel, Bernard Bonnotte, Marc Michel, Maryse Lapeyre-Mestre, Bertrand Godeau

Blood (2022) 140 (Supplement 1): 5557–5558.

https://doi.org/10.1182/blood-2022-157723

Published: 2022

Journal Articles

Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease

Ondine Walter, Pierre Cougoul, Julien Maquet, Pablo Bartolucci, Maryse Lapeyre-Mestre, Margaux Lafaurie, Guillaume Moulis

Blood (2022) 139 (26): 3771–3777.

https://doi.org/10.1182/blood.2021014473

Published: 2022

Includes: Supplemental data

Journal Articles

Risk of Hospitalization for Vaso-Occlusive Episode in Patients with Sickle Cell Disease after out-Patient Exposure to Systemic Corticosteroids

Ondine Walter, Pierre Cougoul, Julien Maquet, Pablo Bartolucci, Maryse Lapeyre-Mestre, Margaux Lafaurie, Guillaume Moulis

Blood (2021) 138 (Supplement 1): 2048.

https://doi.org/10.1182/blood-2021-151307

Published: 2021

Journal Articles

Autoimmune Hemolytic Anemia: A Disease of the Elderly and the Very Elderly with Increased Mortality and Increased Rates of Hospitalization for Thrombosis and Infection

Julien Maquet, Margaux Lafaurie, PharmD, PhDstudent, Agnès Sommet, MD PhD, Maryse Lapeyre-Mestre, MD PhD, Guillaume Moulis

Blood (2020) 136 (Supplement 1): 41.

https://doi.org/10.1182/blood-2020-137545

Published: 2020

Journal Articles

Eltrombopag for Immune Thrombocytopenia in Adult Patients in the Real-World in France. Final Results of the Elextra Study

Guillaume Moulis, Manuela Rueter, MSc, Margaux Lafaurie, PharmD, PhDstudent, Maryse Lapeyre-Mestre, MD PhD

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-139967

Published: 2020

Journal Articles

No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study

Margaux Lafaurie, PharmD, Bérangère Baricault, Vincent Soler, MD PhD, Myriam Cassagne, MD PhD, Laurent Sailler, MD PhD, Maryse Lapeyre-Mestre, MD PhD, Agnès Sommet, MD PhD, Guillaume Moulis, MD PhD

Blood (2019) 134 (Supplement_1): 2363.

https://doi.org/10.1182/blood-2019-124729

Published: 2019

Journal Articles

Eltrombopag for Immune Thrombocytopenia Adult Patients in the Real-Life Practice in France. Interim Results of the Elextra Study

Guillaume Moulis, MD PhD, Manuela Rueter, MSc, Margaux Lafaurie, PharmD, Maryse Lapeyre-Mestre, MD PhD, Carmen investigators Group

Blood (2019) 134 (Supplement_1): 2372.

https://doi.org/10.1182/blood-2019-126000

Published: 2019

Journal Articles

Positivity Rate of Systematic Bone Marrow Smear Above 60-Year-Old Patients with Newly Diagnosed Immune Thrombocytopenia to Screen for Associated Hematological Malignancy. Results from the French Prospective Multicenter Carmen Registry

Blood (2019) 134 (Supplement_1): 1083.

https://doi.org/10.1182/blood-2019-122821

Published: 2019

Journal Articles

Risk of Immune Thrombocytopenia Induced By Influenza Vaccine. a Nationwide Population-Based Study in France

Margaux Lafaurie, PharmD, Bérangère Baricault, Maryse Lapeyre-Mestre, MD PhD, Laurent Sailler, MD PhD, Agnès Sommet, MD PhD, Guillaume Moulis, MD PhD

Blood (2019) 134 (Supplement_1): 1086.

https://doi.org/10.1182/blood-2019-124720

Published: 2019

Journal Articles

Validation of Hemolytic Anemia Codes in the French Hospital Database

Julien Maquet, Hélène Derumeaux, MD PhD, Maryse Lapeyre-Mestre, MD PhD, Laurent Sailler, MD PhD, Guillaume Moulis, MD PhD

Blood (2019) 134 (Supplement_1): 3460.

https://doi.org/10.1182/blood-2019-124697

Published: 2019

Journal Articles

Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study

Guillaume Moulis, MD PhD, Bérangère Baricault, Charlotta Ekstrand, Margaux Lafaurie, PharmD, Christian Fynbo Christiansen, Marie Linder, Shahram Bahmanyar, Mette Nørgaard, MD PhD, Laurent Sailler, MD PhD, Maryse Lapeyre-Mestre, MD PhD

Blood (2018) 132 (Supplement 1): 3745.

https://doi.org/10.1182/blood-2018-99-112506

Published: 2018

Journal Articles

Risk of Vaccine-Induced Immune Thrombocytopenia in Children . Nationwide Case Cross-over and Self-Controlled Case Series Studies in France

Margaux Lafaurie, PharmD, Bérangère Baricault, Maryse Lapeyre-Mestre, MD PhD, Laurent Sailler, MD PhD, Agnès Sommet, MD PhD, Guillaume Moulis, MD PhD

Blood (2018) 132 (Supplement 1): 738.

https://doi.org/10.1182/blood-2018-99-110522

Published: 2018

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Comparative risk of thrombosis in adults with primary immune thrombocytopenia treated with eltrombopag versus romiplostim: A target trial emulation in the french adult immune thrombocytopenia (FAITH) cohort

Association between sars-cov-2 infection, COVID-19 vaccines and immune thrombocytopenia in adults. a nationwide population-based study in France.

Real-world effectiveness and safety of fostamatinib in difficult-to-treat patients: Results of a three-year registry in France.

Risk of Acute Myeloid Leukemia in Adults with Primary Immune Thrombocytopenia Treated with Thrombopoietin Receptor Agonists: A French Nationwide Population-Based Study

Hospitalization for Infection in Patients with Primary Autoimmune Hemolytic Anemia Treated with Rituximab. a Prospective, Nationwide Cohort Study in France

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents

Drug-Induced Autoimmune Hemolytic Anemia: Detection of New Signals in the World Pharmacovigilance Database and Risk Assessment in a Nationwide Cohort Study in France

Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry

Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry

Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease

Risk of Hospitalization for Vaso-Occlusive Episode in Patients with Sickle Cell Disease after out-Patient Exposure to Systemic Corticosteroids

Autoimmune Hemolytic Anemia: A Disease of the Elderly and the Very Elderly with Increased Mortality and Increased Rates of Hospitalization for Thrombosis and Infection

Eltrombopag for Immune Thrombocytopenia in Adult Patients in the Real-World in France. Final Results of the Elextra Study

No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study

Eltrombopag for Immune Thrombocytopenia Adult Patients in the Real-Life Practice in France. Interim Results of the Elextra Study

Positivity Rate of Systematic Bone Marrow Smear Above 60-Year-Old Patients with Newly Diagnosed Immune Thrombocytopenia to Screen for Associated Hematological Malignancy. Results from the French Prospective Multicenter Carmen Registry

Risk of Immune Thrombocytopenia Induced By Influenza Vaccine. a Nationwide Population-Based Study in France

Validation of Hemolytic Anemia Codes in the French Hospital Database

Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study

Risk of Vaccine-Induced Immune Thrombocytopenia in Children . Nationwide Case Cross-over and Self-Controlled Case Series Studies in France

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only